Key clinical point: Three areas of polypharmacy will be tracked in the star-rating system from the Centers for Medicare & Medicaid Services. The new system will replace the high-risk medication measurement that is being retired this year.
Major finding: Health care professionals can use techniques such as medication therapy management and targeted interventions, telephone outreach, and provider detailing to reduce patients’ concomitant use of benzodiazepines and opioids, under one new measure.
Study details: Overview of coming changes to CMS quality measures.
Disclosures: Presenters disclosed no conflicts of interest relevant to their presentation.
Expert presentation at AMCP Nexus 2019, National Harbor, Md.